Shahjahan Shareef, DO
MOHS-Micrographic Surgery · Sarasota, FLNPI 1386184091
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 78 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by AbbVie at 45.4% of the total. Reporting peaked in 2019 at $1,731 and has fallen 85.5% since, to $251 in 2025.
Across 78 payments — averaging $36.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Bristol Myers Squibb$495
- Pfizer$303
- Novartis$179
- Galderma Laboratories, L.p.$164
- Dermira, Inc.$124
- plus $271 from 8 others
What the payments were for
- Food & beverage$2,810100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 41 | $1,275 |
| Bristol Myers Squibb | 12 | $495 |
| Pfizer | 6 | $303 |
| Novartis | 4 | $179 |
| Galderma Laboratories, L.p. | 2 | $164 |
| Dermira, Inc. | 1 | $124 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $94 |
| Regeneron Healthcare Solutions, Inc. | 2 | $52 |
| Sun Pharmaceutical Industries Inc. | 2 | $35 |
| Incyte Corporation | 2 | $26 |
| Merz North America, Inc. | 1 | $24 |
| DUSA Pharmaceuticals, Inc. | 1 | $16 |
| VYNE Pharmaceuticals Inc. | 1 | $12 |
| Amgen | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,810 in reported general payments places this provider in the 60th percentile of 141 mohs-micrographic surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Permethrin | 84 | $26,373 |
| Ketoconazole | 73 | $1,499 |
| Calcipotriene | 11 | $1,263 |
| Doxycycline Hyclate | 121 | $1,214 |
| Triamcinolone Acetonide | 64 | $1,187 |
| Clobetasol Propionate | 28 | $1,144 |
| Gentamicin Sulfate | 20 | $698 |
| Clindamycin Phosphate | 14 | $530 |
| Mupirocin | 68 | $385 |
| Hydrocortisone | 15 | $53 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Sarasota
- Nadia UratoSarasota$6K
- Catherine MotoskoSarasota$3K
- Peter MatteiSarasota$2K
- Andrew WeinsteinBoynton Beach$197K
- Armand CognettaTallahassee$139K
- Scott FoskoGainesville$100K
- Paul BenedettoCoral Springs$96K
- Jeremy SunseriPanama City$81K
- Shawna FlanaganJupiter$74K
- Martin ZaiacMiami Beach$61K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.